Biogen, Inc. (BIIB)
247.29
-4.12
(-1.64%)
USD |
NASDAQ |
Nov 19, 16:00
247.00
-0.29
(-0.12%)
After-Hours: 20:00
Biogen Price : 247.29 for Nov. 19, 2026
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Nov 18, 2026 | 247.78 | 252.79 | 247.00 | 251.41 | 1.145M |
| Nov 17, 2026 | 248.97 | 252.72 | 248.27 | 250.79 | 969020.0 |
| Nov 16, 2026 | 255.25 | 255.42 | 250.65 | 251.65 | 839763.0 |
| Nov 13, 2026 | 250.58 | 255.04 | 249.52 | 253.40 | 1.029M |
| Nov 12, 2026 | 255.00 | 255.05 | 250.43 | 250.48 | 792515.0 |
| Nov 11, 2026 | 249.78 | 255.19 | 249.44 | 253.40 | 1.115M |
| Nov 10, 2026 | 253.56 | 254.70 | 250.44 | 253.25 | 735026.0 |
| Nov 09, 2026 | 250.36 | 261.00 | 246.44 | 254.87 | 1.143M |
| Nov 06, 2026 | 241.28 | 250.03 | 240.00 | 248.35 | 1.002M |
| Nov 05, 2026 | 255.25 | 255.70 | 243.65 | 243.93 | 1.221M |
| Nov 04, 2026 | 253.54 | 255.34 | 246.49 | 254.46 | 1.348M |
| Nov 03, 2026 | 247.32 | 253.14 | 246.25 | 248.93 | 1.058M |
| Nov 02, 2026 | 253.81 | 255.53 | 247.90 | 249.01 | 1.173M |
| Oct 30, 2026 | 255.39 | 258.73 | 251.19 | 253.62 | 1.303M |
| Oct 29, 2026 | 250.15 | 255.55 | 246.48 | 249.65 | 1.158M |
| Oct 28, 2026 | 244.93 | 258.78 | 243.03 | 244.05 | 2.493M |
| Oct 27, 2026 | 250.35 | 253.98 | 248.46 | 252.73 | 1.393M |
| Oct 26, 2026 | 251.02 | 254.11 | 249.61 | 252.26 | 958847.0 |
| Oct 23, 2026 | 251.68 | 252.44 | 246.15 | 250.69 | 1.157M |
| Oct 22, 2026 | 240.61 | 254.41 | 240.02 | 253.84 | 2.238M |
| Oct 21, 2026 | 242.02 | 243.32 | 240.13 | 240.98 | 812899.0 |
| Oct 20, 2026 | 236.79 | 244.65 | 235.96 | 243.10 | 1.492M |
| Oct 19, 2026 | 231.81 | 236.00 | 231.04 | 233.48 | 949716.0 |
| Oct 16, 2026 | 235.75 | 236.87 | 232.36 | 232.65 | 1.463M |
| Oct 15, 2026 | 236.46 | 240.99 | 235.22 | 235.35 | 1.572M |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| Gilead Sciences, Inc. | 166.58 |
| AbbVie, Inc. | 283.59 |
| Amgen, Inc. | 439.06 |
| Eli Lilly & Co. | 1350.07 |
| Regeneron Pharmaceuticals, Inc. | 923.26 |
Price Related Metrics
| PE Ratio | 105.86 |
| PS Ratio | 3.695 |
| Price to Book Value | 1.932 |
| Price to Free Cash Flow | 22.24 |
| Earnings Yield | 0.94% |
| Market Cap | 36.55B |
| Operating PE Ratio | 21.34 |
| Normalized PE Ratio | 32.06 |